Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 48.157 |
|
|||||
| News | - | ||||||
| Tageshoch | 3,29 | Niedrig Hoch |
|||||
| Tagestief | 2,87 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| GT Biopharma Inc | GTBP | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,07 | 2,40% | 2,99 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 2,93 | 2,87 | 3,29 | 2,99 | 2,92 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 467 | 48.157 | US$ 3,03 | US$ 146.070 | - | 2,61 - 11,55 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:48:54 | 20 | US$ 2,96 | USD |
Finanzwerte GTBP
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 4,13M | 1,38M | - | 0 | -7,6M | -5,50 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News GT Biopharma
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 17.6.2024 | 22:26 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 13.6.2024 | 22:14 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 07.6.2024 | 23:25 | Edgar (US Regulatory) | Form 8-K - Current report |
| 24.5.2024 | 02:31 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 23.5.2024 | 12:04 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 23.5.2024 | 12:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15.5.2024 | 23:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 14.2.2024 | 20:46 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 01.2.2024 | 18:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21.12.2023 | 21:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.12.2023 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06.11.2023 | 23:25 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
Forum GT Biopharma
Keine Diskussionen Gefunden.Neuen Thread Erstellen
GTBP Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 2,86 | 3,29 | 2,8118 | 3,05 | 22.896 | 0,13 | 4,55% |
| 1 Monat | 7,66 | 9,59 | 2,61 | 5,44 | 1.104.970 | -4,67 | -60,97% |
| 3 Monate | 4,35 | 10,6599 | 2,61 | 7,21 | 1.484.948 | -1,36 | -31,26% |
| 6 Monate | 7,71 | 10,6599 | 2,61 | 7,18 | 736.818 | -4,72 | -61,22% |
| 1 Jahr | 11,55 | 11,55 | 2,61 | 7,53 | 493.523 | -8,56 | -74,11% |
| 3 Jahre | 529,80 | 554,607 | 2,61 | 64,52 | 304.716 | -526,81 | -99,44% |
| 5 Jahre | 165,00 | 591,993 | 2,61 | 109,20 | 336.123 | -162,01 | -98,19% |
